Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases.
Fo-Ping ChenLi LinJin-Hui LiangSze Huey TanEnya H W OngYing-Shan LuoLuo HuangAdelene Y L SimHai-Tao WangTian-Sheng GaoBin DengGuan-Qun ZhouJia KouMatthew Chin Heng ChuaYing SunPublished in: Therapeutic advances in medical oncology (2021)
Herein, we developed and validated a risk classification system that combines the AJCC/UICC 8th edition TN-stage classification and cfEBV DNA for non-metastatic NPC. Our new clinicomolecular model provides improved OS prediction over the current staging system.